Market Overview

Diabetic Neuropathy| A Pipeline Analysis Report 2018| Technavio


Technavio has announced their latest pipeline analysis report on the diabetic
neuropathy market
. The report includes a detailed analysis of
the pipeline molecules under investigation within the defined data
collection period to treat diabetic neuropathy.

This press release features multimedia. View the full release here:

Technavio has published a new report on the drug development pipeline for diabetic neuropathy, inclu ...

Technavio has published a new report on the drug development pipeline for diabetic neuropathy, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market in the future.

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

Diabetic neuropathy: Market overview

Diabetic neuropathy is a type of nerve damage caused by diabetes. Over
time, hyperglycemia and high levels of fats can damage nerves.
Neuropathy can be caused by both type 1 and type 2 diabetes.
Furthermore, diabetic neuropathy is classified into peripheral
neuropathy, proximal neuropathy, autonomic neuropathy, and focal
neuropathy. The pathogenesis of diabetic neuropathy is complex and is
marked by both metabolic and vascular factors including hyperglycemia,
toxic adiposity, oxidative stress, mitochondrial dysfunction, activation
of the polyol pathway, accumulation of advanced glycation end products,
and elevation of inflammatory markers.

According to a senior market research analyst at Technavio, "According
to the Centers for Disease Control and Prevention, around 60-70% of
people with diabetes have diabetic neuropathy. The highest number of
neuropathic problems are among the people who have had diabetes for at
least 25 years. Also, diabetic nerve problems are more common in people
who have problems in controlling their blood glucose levels, weight, and
blood pressure."

Diabetic neuropathy: Segmentation analysis

This pipeline analysis report segments the diabetic neuropathy market
based on therapies employed (monotherapy and combination therapy), RoA
(oral, topical, intramuscular, and intravenous), therapeutic modality
(small molecule, peptide, biological, monoclonal antibody, cell therapy,
antibody, rhIL-6, and gene therapy), targets (calcium channel,
cannabinoid receptor type 2, TRPV1, and others), MoA (calcium channel
blocker, cannabinoid receptor type 2 agonist, and others), geographical
segmentation (US, Hungary, Japan, South Korea, Poland, Taiwan, Austria,
Germany and others) and recruitment status (active, not recruiting,
completed, planned, and recruiting). It provides an in-depth analysis of
the prominent factors influencing the market, including drivers,
opportunities, trends, and industry-specific challenges.

Based on therapeutic modality, more than 46% of the molecules that are
being investigated for the treatment of diabetic neuropathy are small

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team

View Comments and Join the Discussion!